Canada’s Early Focus on Artificial Intelligence is Starting to Reap Commercial BenefitsUlrik Kristensen2021-11-19T16:52:15+00:00November 19th, 2021|
AI Drug Development Market Projected to Reach $5.1 Billion by 2025Ulrik Kristensen2021-11-19T16:54:14+00:00September 28th, 2021|
AI Business: AI-based drug development startups have raised $2.1bn in the past six monthsUlrik Kristensen2021-11-19T17:03:25+00:00July 21st, 2021|
The Science Advisory Board: AI drug development startups raised $2.1B in 1st half of 2021Ulrik Kristensen2021-09-09T14:35:17+01:00July 19th, 2021|
AI Drug Development Startups Raised $2.1B in H1 2021Ulrik Kristensen2021-11-19T16:54:52+00:00July 6th, 2021|
The Science Advisory Board: Royalties Challenge Risk and Reward in AI Drug DevelopmentUlrik Kristensen2021-06-07T13:49:03+01:00June 7th, 2021|
